hydrochlorothiazide
UkraineDrugs containing this active substance
-
The drug is indicated for adult patients with essential hypertension (high blood pressure) if telmisartan monotherapy does not provide adequate blood pressure control.
Form: tablets
Active substance Dosage telmisartan 80 mg hydrochlorothiazide 12.5 mg ATC: C09DA07
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co. KG (manufacturing, primary and secondary packaging, quality control and batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure).
Form: tablets, film-coated
Active substance Dosage nebivolol 5 mg hydrochlorothiazide 12.5 mg ATC: C07BB12
Manufacturer: Berlin-Chemie AG (manufacturing "in bulk", batch control; final packaging, control and batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure).
Form: tablets, film-coated
Active substance Dosage nebivolol 5 mg hydrochlorothiazide 12.5 mg ATC: C07BB12
-
The drug is used for the treatment of arterial hypertension (high blood pressure).
Form: tablets
Active substance Dosage captopril 50 mg hydrochlorothiazide 25 mg ATC: C09BA01
Manufacturer: JSC "Kyiv Vitamin Plant"
-
These medications are prescribed for the treatment of essential hypertension (high blood pressure) in adults who do not achieve adequate control with a single component (olmesartan medoxomil) alone.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: Alembic Pharmaceuticals Limited
-
These medications are prescribed for the treatment of essential hypertension (high blood pressure) in adults for whom monotherapy (olmesartan medoxomil) is insufficient.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: Alembic Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults who do not achieve sufficient control with olmesartan medoxomil alone.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom treatment with a single component (olmesartan medoxomil) alone is insufficient.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 25 mg ATC: C09DA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom taking a single component (olmesartan medoxomil) alone is insufficient to achieve the required blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom treatment with a single component (olmesartan medoxomil) alone is insufficient.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 25 mg ATC: C09DA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It may also be used as add-on therapy if other drug combinations do not provide adequate blood pressure control, or as a replacement for other agents.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It may also be used as add-on therapy if other combination agents do not provide adequate blood pressure control, or as a replacement for other medications.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure).
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure).
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for adults with essential hypertension (high blood pressure) if the use of a single component (olmesartan medoxomil) alone is insufficient to achieve the desired blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for adults with essential hypertension (high blood pressure) if the use of a single component (olmesartan medoxomil) alone is insufficient to achieve the required blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 25 mg ATC: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for adults with essential hypertension (high blood pressure) for whom the use of a single component (olmesartan) alone does not achieve the required blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for adults with essential hypertension (high blood pressure) if the use of a single component (olmesartan medoxomil) alone is insufficient to achieve the required blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 25 mg ATC: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom monotherapy (olmesartan medoxomil) is insufficient.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: JSC "Kyiv Vitamin Plant"
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in cases where blood pressure control cannot be achieved by taking a single component (losartan or hydrochlorothiazide) alone.
Form: tablets, film-coated
Active substance Dosage losartan 50 mg hydrochlorothiazide 12.5 mg ATC: C09DA01
Manufacturer: Ipca Laboratories Limited
-
The drug is intended for the treatment of arterial hypertension (high blood pressure). It is used in cases where blood pressure cannot be properly controlled using only one component (ramipril or hydrochlorothiazide).
Form: tablets
Active substance Dosage ramipril 5 mg hydrochlorothiazide 25 mg ATC: C09BA05
Manufacturer: Salutas Pharma GmbH (full-cycle manufacturing)
-
The drug is used to treat arterial hypertension (high blood pressure). It is prescribed to patients whose blood pressure cannot be controlled by taking only one component (ramipril or hydrochlorothiazide).
Form: tablets
Active substance Dosage ramipril 5 mg hydrochlorothiazide 25 mg ATC: C09BA05
Manufacturer: Actavis LTD (full-cycle manufacturing)
-
The drug is intended for the treatment of arterial hypertension (high blood pressure). It is used in cases where blood pressure cannot be properly controlled using a single component (ramipril or hydrochlorothiazide) alone.
Form: tablets
Active substance Dosage ramipril 2.5 mg hydrochlorothiazide 12.5 mg ATC: C09BA05
Manufacturer: Actavis LTD (full-cycle manufacturing)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in patients for whom combination therapy is recommended.
Form: tablets
Active substance Dosage ramipril 2.5 mg hydrochlorothiazide 12.5 mg ATC: C09BA05
Manufacturer: Farmak JSC
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in patients for whom combination therapy is recommended.
Form: tablets
Active substance Dosage ramipril 5 mg hydrochlorothiazide 25 mg ATC: C09BA05
Manufacturer: Farmak JSC
-
The drug is intended for the treatment of arterial hypertension (high blood pressure). It is used in cases where blood pressure cannot be properly controlled using only one component (ramipril or hydrochlorothiazide).
Form: tablets
Active substance Dosage ramipril 10 mg hydrochlorothiazide 25 mg ATC: C09BA05
Manufacturer: Farmak JSC
-
The drug is intended for the treatment of arterial hypertension (high blood pressure). It is used in cases where blood pressure cannot be properly controlled using a single component (ramipril or hydrochlorothiazide) alone.
Form: tablets
Active substance Dosage ramipril 5 mg hydrochlorothiazide 12.5 mg ATC: C09BA05
Manufacturer: Farmak JSC
-
The drug is intended for the treatment of arterial hypertension (high blood pressure). It is used in cases where blood pressure cannot be properly controlled using a single component (ramipril or hydrochlorothiazide) alone.
Form: tablets
Active substance Dosage ramipril 10 mg hydrochlorothiazide 12.5 mg ATC: C09BA05
Manufacturer: Farmak JSC
-
The drug is prescribed for the treatment of mild to moderate arterial hypertension (high blood pressure) that requires combination therapy.
Form: tablets
Active substance Dosage lisinopril 20 mg hydrochlorothiazide 12.5 mg ATC: C09BA03
Manufacturer: ALKALOID AD Skopje
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It may also be used as add-on therapy if other drug combinations do not provide adequate blood pressure control, or as a replacement for other agents.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It may also be used as add-on therapy if other combination drugs do not provide adequate blood pressure control, or as a replacement for other medications.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is used to treat edema (in congestive heart failure, liver cirrhosis, or nephrotic syndrome) and to reduce arterial blood pressure in essential hypertension.
Form: tablets, film-coated
Active substance Dosage spironolactone 25 mg hydrochlorothiazide 25 mg ATC: C03EA01
Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.
-
The drug is used to treat edema (in congestive heart failure, liver cirrhosis, or nephrotic syndrome) and to lower blood pressure in essential hypertension.
Form: tablets, film-coated
Active substance Dosage spironolactone 50 mg hydrochlorothiazide 50 mg ATC: C03EA01
Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.
-
The drug is intended for the treatment of mild to moderate arterial hypertension (high blood pressure).
Form: tablets
Active substance Dosage lisinopril 20 mg hydrochlorothiazide 12.5 mg ATC: C09BA03
Manufacturer: KUSUM FARM LLC
-
The drug is intended for the treatment of mild to moderate arterial hypertension (high blood pressure).
Form: tablets
Active substance Dosage lisinopril 10 mg hydrochlorothiazide 12.5 mg ATC: C09BA03
Manufacturer: KUSUM FARM LLC
-
The drug is intended for the treatment of mild to moderate arterial hypertension (high blood pressure).
Form: tablets
Active substance Dosage lisinopril 20 mg hydrochlorothiazide 25 mg ATC: C09BA03
Manufacturer: KUSUM FARM LLC
-
The drug is prescribed for the treatment of arterial hypertension (high blood pressure) in cases where blood pressure cannot be properly controlled using individual drugs at the same doses.
Form: capsules, hard
Active substance Dosage ramipril 5 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09BX03
Manufacturer: Lek Pharmaceuticals d.d. (batch release)
-
The drug is indicated for the treatment of arterial hypertension (high blood pressure) in cases where blood pressure is not controlled by the simultaneous use of individual components of this combination.
Form: capsules, hard
Active substance Dosage ramipril 10 mg amlodipine 5 mg hydrochlorothiazide 25 mg ATC: C09BX03
Manufacturer: Lek Pharmaceuticals d.d. (batch release)
-
The drug is prescribed for the treatment of arterial hypertension (high blood pressure) in cases where blood pressure cannot be properly controlled using single drugs at the same doses.
Form: capsules, hard
Active substance Dosage ramipril 10 mg amlodipine 10 mg hydrochlorothiazide 25 mg ATC: C09BX03
Manufacturer: Lek Pharmaceuticals d.d. (batch release)
-
The drug is intended for adults with arterial hypertension (high blood pressure) if telmisartan alone does not provide adequate blood pressure control.
Form: tablets
Active substance Dosage telmisartan 40 mg hydrochlorothiazide 12.5 mg ATC: C09DA07
Manufacturer: Laboratorio EcEWeRnE, S.A. (alternative unit for conducting analytical tests)
-
The drug is intended for adults with arterial hypertension (high blood pressure) if telmisartan alone does not provide adequate blood pressure control.
Form: tablets
Active substance Dosage telmisartan 80 mg hydrochlorothiazide 25 mg ATC: C09DA07
Manufacturer: Laboratorios Echevarne, S.A. (alternative unit for conducting analytical tests)
-
The drug is intended for adults for the treatment of arterial hypertension (high blood pressure) if telmisartan alone does not provide adequate blood pressure control.
Form: tablets
Active substance Dosage telmisartan 80 mg hydrochlorothiazide 12.5 mg ATC: C09DA07
Manufacturer: Laboratorios Echevarne, S.A. (alternative unit for conducting analytical tests)
-
These medications are prescribed to adults for the treatment of arterial hypertension (high blood pressure) if the use of telmisartan alone does not provide adequate blood pressure control.
Form: tablets
Active substance Dosage telmisartan 40 mg hydrochlorothiazide 12.5 mg ATC: C09DA07
Manufacturer: KRKA, d.d., Novo mesto
-
These medications are prescribed to adults for the treatment of arterial hypertension (high blood pressure) if the use of telmisartan alone does not provide adequate blood pressure control.
Form: tablets
Active substance Dosage telmisartan 80 mg hydrochlorothiazide 25 mg ATC: C09DA07
Manufacturer: KRKA, d.d., Novo mesto
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults.
Form: tablets
Active substance Dosage telmisartan 40 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09DX08
-
These medications are prescribed to adults for the treatment of arterial hypertension (high blood pressure) if the use of telmisartan as a single agent does not provide adequate blood pressure control.
Form: tablets
Active substance Dosage telmisartan 80 mg hydrochlorothiazide 12.5 mg ATC: C09DA07
Manufacturer: KRKA, d.d., Novo mesto
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults.
Form: tablets
Active substance Dosage telmisartan 80 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09DX08
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adult patients.
Form: tablets
Active substance Dosage telmisartan 80 mg amlodipine 10 mg hydrochlorothiazide 12.5 mg ATC: C09DX08
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults.
Form: tablets
Active substance Dosage telmisartan 80 mg amlodipine 10 mg hydrochlorothiazide 25 mg ATC: C09DX08
-
The drug is prescribed for the treatment of arterial hypertension (high blood pressure), especially if the use of telmisartan alone does not provide the desired result.
Form: tablets
Active substance Dosage telmisartan 40 mg hydrochlorothiazide 12.5 mg ATC: C09DA07
Manufacturer: Laboratorios Likonsa, S.A. (full production cycle, batch release)